Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

1-lineage omicron variants of the coronavirus, or SARS-CoV-2. The options include the mRNA vaccines from Pfizer/BioNTech and ...

Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...

This time around, Moderna and Pfizer’s vaccines target the omicron variant known as KP.2 that was common earlier this year, and Novavax’s new vaccine targets KP.2’s parent strain, JN.1. Keep reading ...

The updated vaccine covers all major COVID variants that have developed so far, including previous Omicron strains and the new JN1 variant. Thanks to the flexibility of mRNA technology ...

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

Este artículo estará disponible en español en El Tiempo Latino. Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the fall ...

1 Omicron variant is closely related to ... What about Moderna and Novavax's new COVID-19 vaccines? Pfizer and Moderna COVID-19 vaccines are mRNA-based, while Novavax's is protein-based.

A new variant of COVID called XEC — a combination of two Omicron subvariants — is spreading in the middle of flu season.

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers ...